Kolotilin, Igor
Funding for this research was provided by:
Solar Grants Biotechnology Inc.
Article History
Received: 1 February 2022
Accepted: 7 November 2022
First Online: 14 November 2022
Competing interests
: This study was funded and conducted by Solar Grants Biotechnology Inc., of which Dr. Igor Kolotilin is the founder and Chief Scientific Officer.